Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Midwest Hematology Oncology Group, Incorporated
mi
from
Saint Louis, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Midwest Hematology Oncology Group, Incorporated
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Saint Louis University Cancer Center
mi
from
Saint Louis, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Saint Louis University Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Missouri Baptist Cancer Center
mi
from
Saint Louis, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Missouri Baptist Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Arch Medical Services, Incorporated at Center for Cancer Care and Research
mi
from
Saint Louis, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Arch Medical Services, Incorporated at Center for Cancer Care and Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - St. Louis-Cape Girardeau
mi
from
Saint Louis, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - St. Louis-Cape Girardeau
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
David C. Pratt Cancer Center at St. John's Mercy
mi
from
Saint Louis, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
David C. Pratt Cancer Center at St. John's Mercy
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
St. John's Regional Health Center
mi
from
Springfield, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
St. John's Regional Health Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Billings Clinic - Downtown
mi
from
Billings, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Billings Clinic - Downtown
mi
from
Billings, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
St. James Healthcare Cancer Care
mi
from
Butte, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
St. James Healthcare Cancer Care
mi
from
Butte, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Big Sky Oncology
mi
from
Great Falls, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Big Sky Oncology
mi
from
Great Falls, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Clinical Research Facility
mi
from
Great Falls, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Clinical Research Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
St. Peter's Hospital
mi
from
Helena, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
St. Peter's Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Community Medical Center
mi
from
Missoula, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Community Medical Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Montana Cancer Center
mi
from
Missoula, MT
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Methodist Estabrook Cancer Center
mi
from
Omaha, NE
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Methodist Estabrook Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Immanuel Medical Center
mi
from
Omaha, NE
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Creighton University Medical Center
mi
from
Omaha, NE
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Renown Institute for Cancer at Renown Regional Medical Center
mi
from
Reno, NV
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Renown Institute for Cancer at Renown Regional Medical Center
mi
from
Reno, NV
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Center for Cancer Care at Exeter Hospital
mi
from
Exeter, NH
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Center for Cancer Care at Exeter Hospital
mi
from
Exeter, NH
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hunterdon Regional Cancer Center at Hunterdon Medical Center
mi
from
Flemington, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hunterdon Regional Cancer Center at Hunterdon Medical Center
mi
from
Flemington, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Cancer Institute of New Jersey at Hamilton
mi
from
Hamilton, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Cancer Institute of New Jersey at Hamilton
mi
from
Hamilton, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
mi
from
Marlton, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
mi
from
Marlton, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mountainside Hospital Cancer Center
mi
from
Montclair, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mountainside Hospital Cancer Center
mi
from
Montclair, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Warren Hospital
mi
from
Phillipsburg, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Warren Hospital
mi
from
Phillipsburg, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare
mi
from
Vineland, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare
mi
from
Vineland, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Cancer Institute of New Jersey at Cooper - Voorhees
mi
from
Voorhees, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Cancer Institute of New Jersey at Cooper - Voorhees
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Fox Chase Virtua Health Cancer Program at Virtua West Jersey
mi
from
Voorhees, NJ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Fox Chase Virtua Health Cancer Program at Virtua West Jersey
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
Click here to add this to my saved trials